Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
7.96
+0.08 (1.02%)
At close: Jan 14, 2026, 4:00 PM EST
7.90
-0.06 (-0.71%)
Pre-market: Jan 15, 2026, 8:20 AM EST
Kamada Market Cap
Kamada has a market cap or net worth of $458.16 million as of January 15, 2026. Its market cap has increased by 34.75% in one year.
Market Cap
458.16M
Enterprise Value
394.64M
1-Year Change
34.75%
Ranking
Category
Stock Price
$7.96
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $458.16M, an increase of 32.23%. That is a compound annual growth rate of 2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 457.70M | 12.73% |
| Dec 31, 2025 | 406.00M | 15.97% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
| May 31, 2013 | 346.50M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |